Compounds > 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid
Page last updated: 2024-09-03

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and 11-dehydro-thromboxane b2

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with 11-dehydro-thromboxane b2 in 1 studies

Compound Research Comparison

Studies
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)		Trials
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)		Recent Studies (post-2010)
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)		Studies
(11-dehydro-thromboxane b2)		Trials
(11-dehydro-thromboxane b2)		Recent Studies (post-2010) (11-dehydro-thromboxane b2)
36113808989

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennett, WM; Cannon, C; Hefty, DJ; Jasani, MK; Johnston, T; Kubacki, VB; Martin, LL; Rakhit, A; Schaffer, AV; Smith, SR1

Other Studies

1 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and 11-dehydro-thromboxane b2

ArticleYear
Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity.
    Transplantation, 1993, Volume: 56, Issue:6

    Topics: Adult; Cyclosporine; Glomerular Filtration Rate; Humans; Kidney; Kidney Transplantation; Middle Aged; Pyridines; Thromboxane B2; Thromboxane-A Synthase

1993